Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information - shares
3 Months Ended
Mar. 31, 2023
May 15, 2023
Document Information Line Items    
Entity Registrant Name Unicycive Therapeutics, Inc.  
Trading Symbol UNCY  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   15,233,836
Amendment Flag false  
Entity Central Index Key 0001766140  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-40582  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 81-3638692  
Entity Address, Address Line One 4300 El Camino Real  
Entity Address, Address Line Two Suite 210  
Entity Address, City or Town Los Altos  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94022  
City Area Code (650)  
Local Phone Number 351-4495  
Entity Interactive Data Current Yes  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Security Exchange Name NASDAQ